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The discovery of prions in yeast occurred in different ways. Some (i.e., [PSI + ] and [URE3]) were long known as genetic determinants of mysterious nature until their prion nature was proposed (8) . The others were revealed by purposeful screening of potentially prionogenic proteins and corresponding determinants. The prion-like determinant [ISP + ], described in our earlier work (9) , belongs to the first group, because it was detected as a nonchromosomal antisuppressor in strains containing specific sup35 nonsense suppressor mutations and the nonsense mutations his7-1 (UAA) and lys2-87 (UGA Fig. 2A) . Notably, GuHCl treatment converts these Sup − clones to Sup + (Fig. 2B ). Earlier, we showed that neither HSP104 overexpression nor deletion caused [ISP + ] loss (9) , whereas propagation of yeast prions usually depends on the level of Hsp104 production (13) . We examined the consequences of HSP104 expression from the high copynumber plasmid pLH105 in strains containing the determinant induced by SFP1 overexpression. ] variant of 25-25-2V-P3982 was transformed with pSFP1-GFP, which expressed SFP1-GFP from the GAL1/10 promoter. Of the 674 clones that were isolated from the mitotic progeny of 10 transformants, 577 clones (∼85.6%) switched phenotypes from Sup + to Sup − on galactose-containing medium and retained this phenotype after transfer to glucose-containing medium. The Sup − phenotype that was induced by SFP1-GFP expression was dominant, which was shown in the cross to the [isp ] cells expressing SFP1-GFP both from the galactose-induced promoter and the native SFP1 promoter contained the protein not only in the supernatant but also in the pellet (Fig. 3) .
The ] strain, we observed a weak signal that was distributed between the cytoplasm and nucleus, although the signal was occasionally stronger in the nucleus (Fig. 4A) . A similar pattern of Sfp1-GFP fluorescence has been observed by other authors (15, 16) .
In [ISP   + ] strains, ∼5-7% of cells contained brightly fluorescing foci. Notably, these foci resided both in cells that expressed the Sfp1-GFP from the native SFP1 promoter (Fig. 4B ) and in cells overproducing Sfp1p-GFP (Fig. 4 C and D) . Additionally, in Sfp1-GFPoverexpressing cells, the foci assumed a granular structure ( SFP1 promoter (Fig. 4B) (Fig. 5) . (Fig. 1 A and B) . In an earlier study, we showed that [ISP + ] strains grew faster than isogenic [isp − ] strains (9) . In this study, we expounded on this comparison with two variants of sfp1Δ strain. One was obtained in an [ISP + ] background, and the other was obtained in an [isp − ] background. We showed that both variants of sfp1Δ strain demonstrateded the slowest growth (Fig. 6) . Thus, the influence of Sfp1 prionization on growth rate opposes the effect of SFP1 deletion.
It is known that SFP1 is one of the key genes controlling cell size in yeast (17) (18) (19) ; therefore, cells that lack Sfp1 show a reduced size. At the same time, comparison of cell area (Materials and Methods) showed that [ISP + ] cells are significantly larger than sfp1Δ cells (Table 2) .
Also, taking into account that sfp1 mutations manifest an increased sensitivity to drugs that target translation, such as cycloheximide and paromomycin (20) ] strain, whereas both variants of sfp1Δ strain were more sensitive (Table 3) .
Taken together, our findings suggest that consequences of Sfp1 prion conversion are not equivalent to the loss of Sfp1 function. It should also be noted that the similarity of properties displayed by sfp1Δ derivatives of [ (17); at least two of them, located in the C terminus, are functional (19) . It is the global regulator of transcription that positively controls the expression of ∼10% of all yeast genes, including genes that encode ribosomal proteins and other components of the translational machinery as well as genes that control ribosome biogenesis (15, 16, 19, 20) . It is a component of the target of rapamycin (TOR) signaling pathway, and phosphorylation of Sfp1 by TORC1 kinase regulates its function, particularly nuclear targeting (21) .
Importantly, Sfp1 belongs to a group of asparagine-enriched proteins and was revealed as a potential prion by several computational surveys (5, 22, 23) . We suggest that the prion domain is located in the central region of the protein restricted roughly by positions 230 and 430. This Asn-rich region does not contain functional domains, such as zinc fingers or phosphorylation sites (21) . Location of the prion domain in this region was also predicted by the method developed by Alberti et al. (5) . An exact identification of the prion domain is certainly a separate task for the future.
As /cell/generation (9), whereas switching rates of other prions can be as low as 10 −6 to 10 −7 /cell/generation (24) (25) (26) . The efficiency of [ISP + ] induction by Sfp1 overexpression approximates 70%, whereas it is much lower for other prions. This difference possibly reflects a higher ability of Sfp1 to nucleation and ] cells is less than in supernatants, even when SFP1-GFP is expressed from galactoseinducible promoter (Fig. 3) . It is evident that further study is necessary to resolve this contradiction.
Specific properties of Sfp1 aggregates may underlie the independence of [ISP + ] propagation on Hsp104p. At the same time, we register the curing effect of GuHCl to [ISP + ], although it was weaker than for other yeast prions. These data contradict a well-established mechanism of prion curing by GuHCl through inhibition of Hsp104p ATPase activity (27) and support the idea that an Hsp104-independent pathway of prion shearing may exist (28) . Whether [ISP + ] requires other chaperones for its propagation should be a subject of future studies.
The additional distinction of [ISP + ] from yeast prions characterized at present is its nuclear location. The nuclear location of [ISP + ] was suggested earlier in our work (9) to explain a low efficiency of [ISP + ] transfer by cytoduction compared with other yeast prions. We have also proposed that a protein corresponding to [ISP + ] is a shuttle protein, and its conversion into prion form should hamper its export from the nucleus. These suggestions are now confirmed, at least partially, because Sfp1 is a shuttle protein that operates in the nucleus under normal growth conditions and exits the cytoplasm under stress (15, 19, 21) . Indeed, a nuclear location of its prion form was shown by fluorescence microscopy.
Another ] strain. Although it is believed that prion switching causes a phenotype similar to genetic inactivation of the corresponding gene (1), exclusions from this rule are documented. In the case of the [Het-s] prion of Podospora anserina, the protein acquires a property that triggers vegetative incompatibility by interaction with the product of another allele of the same gene in heterokaryotic mycelia (29) . However, the exact explanation of this phenomenon is complicated by gaps in our knowledge of the molecular mechanisms of incompatibility in fungi. Formally, the [PIN + ] prion in yeast may also be attributed as one of such exclusions, because prion switching transforms the corresponding protein, Rnq1, into a template for the polymerization of some other prion proteins (30, 31) . It is unclear, however, how Rnq1 prionization influences its own functioning, because Rnq1 functions, besides its influence on induction of other prions, are not known.
In (Fig. 6 and Table 3 ). Interestingly, from seven yeast prions described to date, four proteins-Ure2, Swi1, Cyc8, and Mot3-participate in regulation of gene expression. Sfp1 should be added to this list. Whether the ability of these proteins to switch into prion form is related to their functions remains to be established. Plasmids. pRS425-SFP1 and pRS426-SFP1, the derivatives of pRS425 and pRS426 containing SFP1, were generated by cloning SFP1 by PCR of the chromosomal SFP1 copy from 2V-P3982. pMT3193 contained SFP1 under the control of its own promoter, and pMT3453 expressed GFP-SFP1 under the control of the SFP1 promoter (16) . Both pMT3193 and pMT3453 were provided by M. Tyers (Toronto, ON, Canada). The ORF plus 799 bp of upstream and 300 bp of downstream sequence of SFP1 from pMT3193 was cloned into pRS315 to generate pRS315-SFP1. pSFP1-GFP, obtained from A. Vershon's laboratory (Piscataway, NJ), contained the entire SFP1 gene, fused in frame to the 5′ end of the GFP gene, under control of the GAL1/GAL10 promoter (19) . A 2-μm plasmid, pLH105, containing HSP104 under control of the constitutively activated GPD promoter, was obtained from the Y. Chernoff laboratory (Atlanta, GA) (35) . The pCORE plasmid (36) was used to replace SFP1 with URA3.
Materials and Methods
Yeast Culture and Media. Yeast cultures were grown at 26°C in rich medium YPD, supplemented minimal medium (SMM), or SMM lacking one or more supplements (e.g., SMM-lysine). All media were prepared as described (37 ]-based antisuppression was clearer for lys2-87 than for his7-1; in these cases, results that were obtained using SMM-Lys are presented.
GuHCl treatment and subsequent examination of the clones were performed as described (38) . The drug-sensitivity test was carried out as described (19) using paromomycin and cycloheximide (Sigma).
Fluorescence Microscopy. A fluorescence assay of GFP fusion proteins was performed using a Leica DM6000B Leica Microsystems GmBH with Leica QWin Standard software (version 3.2.0). DAPI (Invitrogen) staining was performed according to the manufacturer's protocol.
Preparation, Fractionation, and Analysis of Yeast-Cell Lysates. Protein isolation and differential centrifugation were performed accordingly to protocol described in ref. 39 . Fractionation of cell lysates was performed at 13,000 × g for 20 min. After SDS/PAGE in 12% gel, proteins were transferred onto a PVDF membrane. Western blotting was performed with primary monoclonal antibody 3A9 against GFP obtained from the Institute of Bioorganic Chemistry in Moscow, Russia. Reactions with the secondary anti-mouse antibodies as well as chemiluminescent detection were performed with the use of ECL detection kit (General Electric). Staining of gel with Coomassie Blue was used for normalization of the total protein amount.
Cell-Size Evaluation. Strains were grown in YPD up to the early stationary phase. Then, cells were placed in a counting chamber (hemocytometer) and examined in transmitted light under a Leica DM LS microscope equipped with FLUOTAR objective 20×/0.40 photoadapter Leica DFC 320 camera. Images were captured with Leica DFC Twain software and processed with Adobe Photoshop CS2. The photographed cell area was estimated using the ImageJ 1.34s program (http:// rsb.info.nih.gov/ij/). Student t test was used for statistical evaluation of the data.
